"Visitation restrictions are currently in place to decrease possible exposure to Coronavirus (COVID-19). Please visit our website for more information. CHI Health Creighton University Medical Center - Bergan Mercy is dedicated to delivering high quality, compassionate care to Omaha and nearby communities. Visit us at 7500 Mercy Rd or call (402) 398-6060 for more information."

During the past decade, Alegent Health Bergan Mercy Medical Center conducted 155 clinical trials. In the 10-year time frame, 155 clinical trials started and 100 clinical trials were completed, i.e. on average, 64.5% percent of trials that started reached the finish line to date. In the past 5 years, 64 clinical trials started and 61 clinical trials were completed. i.e. 95.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Alegent Health Bergan Mercy Medical Center" #1 sponsor was "National Cancer Institute (NCI)" with 130 trials, followed by "SWOG Cancer Research Network" with 36 trials sponsored, "Alliance for Clinical Trials in Oncology" with 32 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 18 trials sponsored and "NRG Oncology" with 18 trials sponsored. Other sponsors include 33 different institutions and companies that sponsored additional 21 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Alegent Health Bergan Mercy Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 117 trials as a collaborator, "NRG Oncology" with 33 trials as a collaborator, "Canadian Cancer Trials Group" with 8 trials as a collaborator, "SWOG Cancer Research Network" with 6 trials as a collaborator and "Cancer and Leukemia Group B" with 5 trials as a collaborator. Other collaborators include 43 different institutions and companies that were collaborators in the rest 34 trials.

According to Clinical.Site data, the most researched conditions in "Alegent Health Bergan Mercy Medical Center" are "Breast Cancer" (13 trials), "Recurrent Breast Carcinoma" (9 trials), "Recurrent Ovarian Carcinoma" (9 trials), "Recurrent Squamous Cell Lung Carcinoma" (9 trials) and "Invasive Breast Carcinoma" (8 trials). Many other conditions were trialed in "Alegent Health Bergan Mercy Medical Center" in a lesser frequency.

Most popular intervention types in "Alegent Health Bergan Mercy Medical Center" are "Drug" (201 trials), "Other" (158 trials), "Biological" (117 trials), "Procedure" (63 trials) and "Radiation" (45 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (86 trials), "Quality-of-Life Assessment" (63 trials), "Questionnaire Administration" (35 trials), "Computed Tomography" (34 trials) and "Paclitaxel" (31 trials). Other intervention names were less common.

The vast majority of trials in "Alegent Health Bergan Mercy Medical Center" are 205 trials for "All" genders, 48 trials for "Female" genders and 9 trials for "Male" genders.

Currently, there are NaN active trials in "Alegent Health Bergan Mercy Medical Center". undefined are not yet recruiting, 62 are recruiting, 119 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 65 completed trials in Alegent Health Bergan Mercy Medical Center, 3 suspended trials, and 10 terminated clinical trials to date.

Out of the total trials that were conducted in Alegent Health Bergan Mercy Medical Center, 10 "Phase 1" clinical trials were conducted, 118 "Phase 2" clinical trials and 138 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 11 trials that are defined as “Not Applicable".